MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
Stanford University
Stanford, Estados UnidosPublications in collaboration with researchers from Stanford University (6)
2017
-
Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia
Blood Advances, Vol. 1, Núm. 21, pp. 1807-1814
2015
-
High Δnp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia
Blood, Vol. 126, Núm. 20, pp. 2302-2306
2014
-
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study
Annals of Hematology, Vol. 93, Núm. 12, pp. 2001-2010
-
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: An International Consortium on Acute Promyelocytic Leukaemia study
British Journal of Haematology, Vol. 166, Núm. 4, pp. 540-549
2013
-
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
Blood, Vol. 121, Núm. 11, pp. 1935-1943
1998
-
Prognostic factors and scoring systems in myelodysplastic syndromes
Haematologica, Vol. 83, Núm. 4, pp. 358-368